The release of heavy documents, the ophthalmic medical market may have major changes

In recent years, under the background of deepening aging, increasing work intensity, and changing life>
.
In this context, in order to further improve the people's eye health level and continue to promote the high-quality development of China's eye health cause, the state has begun to issue a series of documents to promote the development of China's eye health work
.
For example, in October 2016, the "13th Five-Year" National Eye Health Plan (2016-2020) issued by the National Health and Family Planning Commission proposed to further improve CSR (the rate of cataract surgery for one million people per year), strengthen diabetic retina Early diagnosis and treatment of lesions, and strengthening of refractive screening of children and adolescents, in August 2017, the National Health and Family Planning Commission approved the establishment of independent medical institution categories for small and medium-sized eye hospitals, allowing social forces to invest in chain and group operations
.
It is worth noting that recently, the National Health and Medical Commission recently released the "14th Five-Year Plan for National Eye Health (2021-2025)"
.
The "Plan" pointed out that it is necessary to focus on key groups and key eye diseases
.
Focus on the two key groups of children, adolescents and the elderly, focus on key eye diseases such as myopia and other refractive errors, cataracts, fundus diseases, glaucoma, and corneal blindness, promote appropriate technologies and diagnosis and treatment models for the prevention and treatment of eye diseases, and improve the eye health of key populations
.
Among them, it is also clearly stated that by 2025, we will strive to achieve the following goals: including the coverage rate of eye care and vision examinations for children aged 0-6 years above 90%, the overall level of children and adolescents' eye health continues to improve; effective refractive error correction coverage The number of people suffering from visual impairment caused by high myopia has gradually decreased; the national CSR has reached more than 3,500, and the coverage of effective cataract surgery has continued to increase
.
The industry believes that the entire ophthalmology industry will show a strong growth trend under the background of continuous favorable policies and huge space for the demand market
.
Especially with the release of the "14th Five-Year Plan for National Eye Health (2021-2025)", the ophthalmology market will expand rapidly, and the development of the entire market will also undergo more changes.

.
It is understood that the ophthalmology market as a whole can be divided into upstream ophthalmic medical devices, pharmaceuticals, and downstream medical service industries
.
Among them, in some areas, the market has been occupied by foreign companies
.
Taking ophthalmic medical devices as an example, China's market concentration in this field has always been relatively low
.
According to data, the top three companies in China's ophthalmic medical device market in 2019 are Novartis, Dr.
Lun and Johnson & Johnson, with a market share of 7.
2%, 6.
8%, and 5.
9%, respectively
.
Although the proportion is not high, as the ophthalmology market is more and more optimistic and the policy continues to help, related companies have begun to accelerate the expansion of the market
.
The industry expects that ophthalmic medical devices, pharmaceuticals, and the downstream medical service industry will enter a new stage of development, and the market will also usher in a major reshuffle.
, Process medical device companies with perfect product layout and standardized operation are expected to gain more opportunities
.